Ferric gluconate (BioDeep_00000844286)
代谢物信息卡片
Ferric gluconate
化学式: C18H33FeO21 (641.0863658000001)
中文名称:
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: C(C(C(C(C(C(=O)[O-])O)O)O)O)O.C(C(C(C(C(C(=O)[O-])O)O)O)O)O.C(C(C(C(C(C(=O)[O-])O)O)O)O)O.[Fe+3]
InChI: /q
描述信息
D006401 - Hematologic Agents > D006397 - Hematinics > D005290 - Ferric Compounds
同义名列表
2 个代谢物同义名
数据库引用编号
6 个数据库交叉引用编号
- ChEBI: CHEBI:34762
- PubChem: 656646
- CAS: 38658-53-6
- PubChem: 853885
- KEGG: C13511
- KNApSAcK: 34762
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Itay Borreda, Robert Zukermann, Danny Epstein, Erez Marcusohn. IV Sodium Ferric Gluconate Complex in Patients Hospitalized Due to Acute Decompensated Heart Failure and Iron Deficiency.
Journal of cardiovascular pharmacology and therapeutics.
2022 Jan; 27(?):10742484211055639. doi:
10.1177/10742484211055639. [PMID: 34994220] - Joel E P Brandis, Kyle C Kihn, Marc B Taraban, Julia Schnorr, Alex M Confer, Sharon Batelu, Dajun Sun, Jason D Rodriguez, Wenlei Jiang, David P Goldberg, Peter Langguth, Timothy L Stemmler, Yihua Bruce Yu, Maureen A Kane, James E Polli, Sarah L J Michel. Evaluation of the Physicochemical Properties of the Iron Nanoparticle Drug Products: Brand and Generic Sodium Ferric Gluconate.
Molecular pharmaceutics.
2021 04; 18(4):1544-1557. doi:
10.1021/acs.molpharmaceut.0c00922. [PMID: 33621099] - Eleonora Riccio, Massimo Sabbatini, Ivana Capuano, Angela Maria Pellegrino, Luigi Annicchiarico Petruzzelli, Antonio Pisani. Oral Sucrosomial® iron versus intravenous iron for recovering iron deficiency anaemia in ND-CKD patients: a cost- minimization analysis.
BMC nephrology.
2020 02; 21(1):57. doi:
10.1186/s12882-020-01716-w. [PMID: 32087684] - Chieh-Li Yen, Yu-Sheng Lin, Yueh-An Lu, Hsin-Fu Lee, Cheng-Chia Lee, Ying-Chang Tung, George Kuo, Lung-Sheng Wu, Ya-Chung Tian, Pao-Hsien Chu. Intravenous iron supplementation does not increase infectious disease risk in hemodialysis patients: a nationwide cohort-based case-crossover study.
BMC nephrology.
2019 08; 20(1):327. doi:
10.1186/s12882-019-1495-7. [PMID: 31438879] - Heather M Neu, Sergei A Alexishin, Joel E P Brandis, Anne M C Williams, Wenjing Li, Dajun Sun, Nan Zheng, Wenlei Jiang, Ann Zimrin, Jeffrey C Fink, James E Polli, Maureen A Kane, Sarah L J Michel. Snapshots of Iron Speciation: Tracking the Fate of Iron Nanoparticle Drugs via a Liquid Chromatography-Inductively Coupled Plasma-Mass Spectrometric Approach.
Molecular pharmaceutics.
2019 03; 16(3):1272-1281. doi:
10.1021/acs.molpharmaceut.8b01215. [PMID: 30676753] - Kimberley Span, Ebel H E Pieters, Vera Brinks, Wim E Hennink, Huub Schellekens. Evaluation of the suitability of a Sprague Dawley rat model to assess intravenous iron preparations.
Journal of pharmacological and toxicological methods.
2018 May; 91(?):7-17. doi:
10.1016/j.vascn.2017.12.001. [PMID: 29278742] - Biagio R Di Iorio, Lucia Di Micco, Luigi Russo, Luca Nardone, Emanuele De Simone, M L Sirico, Gabriella Di Natale, Domenico Russo. A strategy to reduce inflammation and anemia treatment's related costs in dialysis patients.
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia.
2018 Feb; 35(1):. doi:
NULL. [PMID: 29390245] - Peng Zou, Katherine Tyner, Andre Raw, Sau Lee. Physicochemical Characterization of Iron Carbohydrate Colloid Drug Products.
The AAPS journal.
2017 09; 19(5):1359-1376. doi:
10.1208/s12248-017-0126-0. [PMID: 28762128] - Wolfgang C Winkelmayer, Benjamin A Goldstein, Aya A Mitani, Victoria Y Ding, Medha Airy, Sreedhar Mandayam, Tara I Chang, M Alan Brookhart, Steven Fishbane. Safety of Intravenous Iron in Hemodialysis: Longer-term Comparisons of Iron Sucrose Versus Sodium Ferric Gluconate Complex.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2017 Jun; 69(6):771-779. doi:
10.1053/j.ajkd.2016.10.031. [PMID: 28063734] - Michael Auerbach, Iain Macdougall. The available intravenous iron formulations: History, efficacy, and toxicology.
Hemodialysis international. International Symposium on Home Hemodialysis.
2017 06; 21 Suppl 1(?):S83-S92. doi:
10.1111/hdi.12560. [PMID: 28371203] - Lisa H Fell, Sarah Seiler-Mußler, Alexander B Sellier, Björn Rotter, Peter Winter, Martina Sester, Danilo Fliser, Gunnar H Heine, Adam M Zawada. Impact of individual intravenous iron preparations on the differentiation of monocytes towards macrophages and dendritic cells.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2016 11; 31(11):1835-1845. doi:
10.1093/ndt/gfw045. [PMID: 27190361] - Carla Rognoni, Sergio Venturini, Michela Meregaglia, Melania Marmifero, Rosanna Tarricone. Efficacy and Safety of Ferric Carboxymaltose and Other Formulations in Iron-Deficient Patients: A Systematic Review and Network Meta-analysis of Randomised Controlled Trials.
Clinical drug investigation.
2016 Mar; 36(3):177-94. doi:
10.1007/s40261-015-0361-z. [PMID: 26692005] - Richa Pandey, Reem Daloul, Daniel W Coyne. Iron Treatment Strategies in Dialysis-Dependent CKD.
Seminars in nephrology.
2016 03; 36(2):105-11. doi:
10.1016/j.semnephrol.2016.02.004. [PMID: 27236131] - M Alan Brookhart, Janet K Freburger, Alan R Ellis, Wolfgang C Winkelmayer, Lily Wang, Abhijit V Kshirsagar. Comparative Short-term Safety of Sodium Ferric Gluconate Versus Iron Sucrose in Hemodialysis Patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2016 Jan; 67(1):119-27. doi:
10.1053/j.ajkd.2015.07.026. [PMID: 26385819] - Medha Airy, Sreedhar Mandayam, Aya A Mitani, Tara I Chang, Victoria Y Ding, M Alan Brookhart, Benjamin A Goldstein, Wolfgang C Winkelmayer. Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2015 Dec; 30(12):2068-75. doi:
10.1093/ndt/gfv305. [PMID: 26311216] - Zaher Armaly, Amir Abd El Qader, Adel Jabbour, Kamal Hassan, Rawi Ramadan, Abdalla Bowirrat, Bishara Bisharat. Effects of carnitine on oxidative stress response to intravenous iron administration to patients with CKD: impact of haptoglobin phenotype.
BMC nephrology.
2015 Aug; 16(?):135. doi:
10.1186/s12882-015-0119-0. [PMID: 26268514] - U Schatz, B M W Illigens, T Siepmann, B Arneth, G Siegert, D Siegels, F Heigl, R Hettich, W Ramlow, H Prophet, S R Bornstein, U Julius. TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients --A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltose.
Atherosclerosis. Supplements.
2015 May; 18(?):199-208. doi:
10.1016/j.atherosclerosissup.2015.02.030. [PMID: 25936327] - James R Connor, Xuesheng Zhang, Anne M Nixon, Becky Webb, Joseph R Perno. Comparative evaluation of nephrotoxicity and management by macrophages of intravenous pharmaceutical iron formulations.
PloS one.
2015; 10(5):e0125272. doi:
10.1371/journal.pone.0125272. [PMID: 25973894] - S A Potthoff, H G Münch. [Safety aspects of parenteral iron supplementation therapies in patients with chronic kidney disease].
Deutsche medizinische Wochenschrift (1946).
2013 Jun; 138(24):1312-7. doi:
10.1055/s-0033-1343219. [PMID: 23737117] - Katie Palmer, Karen Cameron, Marisa Battistella. Review of available intravenous iron preparations in hemodialysis.
CANNT journal = Journal ACITN.
2013 Apr; 23(2):51-4; quiz 55. doi:
NULL. [PMID: 24069699] - Corinne Seng Yue, Keith Gallicano, Line Labbé, Murray P Ducharme. Novel population pharmacokinetic method compared to the standard noncompartmental approach to assess bioequivalence of iron gluconate formulations.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
2013; 16(3):424-40. doi:
10.18433/j3hs42. [PMID: 24021291] - L Santarpia, M C Pagano, R Cuomo, L Alfonsi, F Contaldo, F Pasanisi. Iron absorption following a single oral dose of ferrous sulfate or ferric gluconate in patients with gastrectomy.
Annals of nutrition & metabolism.
2013; 63(1-2):55-9. doi:
10.1159/000351447. [PMID: 23899667] - Karen Shalansky, Jennifer Hanko, Morris Pudek, Guiyun Li, Jacek Jastrzebski. Iron indices after administration of sodium ferric gluconate complex in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2011 Oct; 58(4):684-5. doi:
10.1053/j.ajkd.2011.05.021. [PMID: 21840100] - David Baribeault. Sodium ferric gluconate (SFG) in complex with sucrose for IV infusion: bioequivalence of a new generic product with the branded product in healthy volunteers.
Current medical research and opinion.
2011 Aug; 27(8):1653-7. doi:
10.1185/03007995.2011.597738. [PMID: 21714710] - Victoria A Kumar, Dean A Kujubu, John J Sim, Scott A Rasgon, Philip S Yang. Vitamin D supplementation and recombinant human erythropoietin utilization in vitamin D-deficient hemodialysis patients.
Journal of nephrology.
2011 Jan; 24(1):98-105. doi:
10.5301/jn.2010.1830. [PMID: 20563998] - Wissam Mansour, Melisha Bissram, Mitchell H Rosner. Intravenous iron therapy and risk for progressive loss of kidney function in patients with chronic kidney disease.
Nephron. Clinical practice.
2011; 118(2):c189-94. doi:
10.1159/000320707. [PMID: 21178375] - Rajiv Agarwal, David J Leehey, Scott M Olsen, Naomi V Dahl. Proteinuria induced by parenteral iron in chronic kidney disease--a comparative randomized controlled trial.
Clinical journal of the American Society of Nephrology : CJASN.
2011 Jan; 6(1):114-21. doi:
10.2215/cjn.06020710. [PMID: 20876669] - Andreas Drynda, René Hoehn, Matthias Peuster. Influence of Fe(II) and Fe(III) on the expression of genes related to cholesterol- and fatty acid metabolism in human vascular smooth muscle cells.
Journal of materials science. Materials in medicine.
2010 May; 21(5):1655-63. doi:
10.1007/s10856-010-4014-8. [PMID: 20162334] - Amit Sharma, Kirsten Vanderhalt, Kenneth J Ryan, Jo Sclafani. Refining the approach to IV iron use in hemodialysis patients: a post-DRIVE analysis.
Nephrology news & issues.
2010 Apr; 24(4):22-6, 29. doi:
NULL. [PMID: 20458992] - Thomas Rath, Kai Florschütz, Klaus Kalb, Uwe Rothenpieler, Jörg Schletter, Wolfgang Seeger, Stefan Zinn. Low-molecular-weight iron dextran in the management of renal anaemia in patients on haemodialysis--the IDIRA Study.
Nephron. Clinical practice.
2010; 114(1):c81-8. doi:
10.1159/000253958. [PMID: 19887827] - Brigitte Sturm, Hannes Steinkellner, Nina Ternes, Hans Goldenberg, Barbara Scheiber-Mojdehkar. In vitro study on the effects of iron sucrose, ferric gluconate and iron dextran on redox-active iron and oxidative stress.
Arzneimittel-Forschung.
2010; 60(7):459-65. doi:
10.1055/s-0031-1296312. [PMID: 20712137] - Timothy V Nguyen. Comparison of serum ferritin and transferrin saturation values associated with two i.v. iron formulations in hemodialysis patients.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
2009 Jun; 66(12):1101-4. doi:
10.2146/ajhp080220. [PMID: 19498125] - Hassan N Ibrahim, Robert N Foley, Rui Zhang, David T Gilbertson, Allan J Collins. Parenteral iron use: possible contribution to exceeding target hemoglobin in hemodialysis patients.
Clinical journal of the American Society of Nephrology : CJASN.
2009 Mar; 4(3):623-9. doi:
10.2215/cjn.03850808. [PMID: 19211669] - Victor E Pollak, Jonathan A Lorch, Rakesh Shukla, Supriya Satwah. The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data.
BMC nephrology.
2009 Feb; 10(?):6. doi:
10.1186/1471-2369-10-6. [PMID: 19245700] - Laura T Pizzi, Thomas J Bunz, Daniel W Coyne, David S Goldfarb, Ajay K Singh. Ferric gluconate treatment provides cost savings in patients with high ferritin and low transferrin saturation.
Kidney international.
2008 Dec; 74(12):1588-95. doi:
10.1038/ki.2008.489. [PMID: 19034302] - Toros Kapoian. Challenge of effectively using erythropoiesis-stimulating agents and intravenous iron.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2008 Dec; 52(6 Suppl):S21-8. doi:
10.1053/j.ajkd.2008.09.004. [PMID: 19010258] - Eric L Eisenstein. DRIVE it home: making the case for prospective economic data collection in randomized clinical trials.
Kidney international.
2008 Dec; 74(12):1507-9. doi:
10.1038/ki.2008.553. [PMID: 19034299] - Daniel W Coyne, Andrea Sims, Brenda Bingel. Results of an anemia management program to reduce high epoetin doses by targeted use of i.v. ferric gluconate.
Nephrology nursing journal : journal of the American Nephrology Nurses' Association.
2008 Nov; 35(6):583-7. doi:
NULL. [PMID: 19260610] - Toros Kapoian, Neeta B O'Mara, Ajay K Singh, John Moran, Adel R Rizkala, Robert Geronemus, Robert C Kopelman, Naomi V Dahl, Daniel W Coyne. Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin.
Journal of the American Society of Nephrology : JASN.
2008 Feb; 19(2):372-9. doi:
10.1681/asn.2007050606. [PMID: 18216316] - B L Jaber. Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease.
Kidney international.
2008 Feb; 73(4):511-2; author 512. doi:
10.1038/sj.ki.5002756. [PMID: 18235527] - Suxin Wang, Gina Geraci, Martin K Kuhlmann, Nathan W Levin, Garry J Handelman. Chemical reactions of vitamin C with intravenous-iron formulations.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2008 Jan; 23(1):120-5. doi:
10.1093/ndt/gfm557. [PMID: 17951305] - Ganguli Anirban, H S Kohli, Vivekanand Jha, K L Gupta, Vinay Sakhuja. The comparative safety of various intravenous iron preparations in chronic kidney disease patients.
Renal failure.
2008; 30(6):629-38. doi:
10.1080/08860220802134631. [PMID: 18661414] - Bradley A Warady, Paul A Seligman, Naomi V Dahl. Single-dosage pharmacokinetics of sodium ferric gluconate complex in iron-deficient pediatric hemodialysis patients.
Clinical journal of the American Society of Nephrology : CJASN.
2007 Nov; 2(6):1140-6. doi:
10.2215/cjn.00830207. [PMID: 17942782] - R Agarwal, A R Rizkala, M O Kaskas, R Minasian, J R Trout. Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease.
Kidney international.
2007 Sep; 72(5):638-42. doi:
10.1038/sj.ki.5002422. [PMID: 17622274] - Heather J Miller, James Hu, Johanna K Valentine, Preston S Gable. Efficacy and tolerability of intravenous ferric gluconate in the treatment of iron deficiency anemia in patients without kidney disease.
Archives of internal medicine.
2007 Jun; 167(12):1327-8. doi:
10.1001/archinte.167.12.1327. [PMID: 17592108] - Amedeo F de Vecchi, Cristina Novembrino, Silvia Lonati, Silvia Ippolito, Fabrizia Bamonti. Two different modalities of iron gluconate i.v. administration: effects on iron, oxidative and inflammatory status in peritoneal dialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2007 Jun; 22(6):1709-13. doi:
10.1093/ndt/gfm005. [PMID: 17298995] - Robert C Kopelman, Lorelei Smith, Leonard Peoples, Ronna Biesecker, Adel R Rizkala. Functional iron deficiency in hemodialysis patients with high ferritin.
Hemodialysis international. International Symposium on Home Hemodialysis.
2007 Apr; 11(2):238-46. doi:
10.1111/j.1542-4758.2007.00175.x. [PMID: 17403177] - Amy Barton Pai, Alex V Boyd, Charles R McQuade, Antonia Harford, Jeffrey P Norenberg, Philip G Zager. Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis.
Pharmacotherapy.
2007 Mar; 27(3):343-50. doi:
10.1592/phco.27.3.343. [PMID: 17316146] - Daniel W Coyne, Toros Kapoian, Wadi Suki, Ajay K Singh, John E Moran, Naomi V Dahl, Adel R Rizkala. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study.
Journal of the American Society of Nephrology : JASN.
2007 Mar; 18(3):975-84. doi:
10.1681/asn.2006091034. [PMID: 17267740] - David H Henry, Naomi V Dahl, Michael Auerbach, Simon Tchekmedyian, Leslie R Laufman. Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy.
The oncologist.
2007 Feb; 12(2):231-42. doi:
10.1634/theoncologist.12-2-231. [PMID: 17296819] - G Sirken, R Raja, A R Rizkala. Association of different intravenous iron preparations with risk of bacteremia in maintenance hemodialysis patients.
Clinical nephrology.
2006 Nov; 66(5):348-56. doi:
10.5414/cnp66348. [PMID: 17140164] - Kalkidan Bishu, Rajiv Agarwal. Acute injury with intravenous iron and concerns regarding long-term safety.
Clinical journal of the American Society of Nephrology : CJASN.
2006 Sep; 1 Suppl 1(?):S19-23. doi:
10.2215/cjn.01420406. [PMID: 17699372] - Richard A Zager. Parenteral iron compounds: potent oxidants but mainstays of anemia management in chronic renal disease.
Clinical journal of the American Society of Nephrology : CJASN.
2006 Sep; 1 Suppl 1(?):S24-31. doi:
10.2215/cjn.01410406. [PMID: 17699373] - David H Henry. The role of intravenous iron in cancer-related anemia.
Oncology (Williston Park, N.Y.).
2006 Jul; 20(8 Suppl 6):21-4. doi:
NULL. [PMID: 16925107] - A Besarab. Resolving the paradigm crisis in intravenous iron and erythropoietin management.
Kidney international. Supplement.
2006 May; ?(101):S13-8. doi:
10.1038/sj.ki.5000405. [PMID: 16830701] - Frederick J Kaskel. Safety and efficacy of sodium ferric gluconate complex in iron-deficient pediatric hemodialysis patients.
Nature clinical practice. Nephrology.
2006 May; 2(5):244-5. doi:
10.1038/ncpneph0155. [PMID: 16932433] - Beatriz Bayés, Mari Cruz Pastor, Jordi Bonal, Andreu Foraster, Ramón Romero. Oxidative stress, inflammation and cardiovascular mortality in haemodialysis--role of seniority and intravenous ferrotherapy: analysis at 4 years of follow-up.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2006 Apr; 21(4):984-90. doi:
10.1093/ndt/gfi294. [PMID: 16326744] - Bradley A Warady, R Howard Zobrist, Eileen Finan. Sodium ferric gluconate complex maintenance therapy in children on hemodialysis.
Pediatric nephrology (Berlin, Germany).
2006 Apr; 21(4):553-60. doi:
10.1007/s00467-006-0042-5. [PMID: 16520948] - Lazaro Gotloib, Donald Silverberg, Roberto Fudin, Avshalom Shostak. Iron deficiency is a common cause of anemia in chronic kidney disease and can often be corrected with intravenous iron.
Journal of nephrology.
2006 Mar; 19(2):161-7. doi:
NULL. [PMID: 16736414] - Rajiv Agarwal, Adel R Rizkala, Bahar Bastani, Marwan O Kaskas, David J Leehey, Anatole Besarab. A randomized controlled trial of oral versus intravenous iron in chronic kidney disease.
American journal of nephrology.
2006; 26(5):445-54. doi:
10.1159/000096174. [PMID: 17035697] - Juergensen Peter, Fredric Finkelstein. The effectiveness of low-dose maintenance i.v. iron therapy: a dialysis facility's experience.
Nephrology nursing journal : journal of the American Nephrology Nurses' Association.
2006 Jan; 33(1):71-4, 90. doi:
NULL. [PMID: 16538930] - Leopold J Anghileri, Emilio Mayayo, José L Domingo. Iron-radiofrequency synergism in lymphomagenesis.
Immunopharmacology and immunotoxicology.
2006; 28(1):175-83. doi:
10.1080/08923970600626213. [PMID: 16684676] - Christopher A Laman, Scott B Silverstein, George M Rodgers. Parenteral iron therapy: a single institution's experience over a 5-year period.
Journal of the National Comprehensive Cancer Network : JNCCN.
2005 Nov; 3(6):791-5. doi:
10.6004/jnccn.2005.0047. [PMID: 16316614] - Monica Utley. Effective and safe IV iron and anemia management during home hemodialysis: a dialysis facility's experience.
Nephrology nursing journal : journal of the American Nephrology Nurses' Association.
2005 Nov; 32(6):659-65; quiz 666. doi:
NULL. [PMID: 16425811] - Wendy L St Peter, Gregorio T Obrador, Tricia L Roberts, Allan J Collins. Trends in intravenous iron use among dialysis patients in the United States (1994-2002).
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2005 Oct; 46(4):650-60. doi:
10.1053/j.ajkd.2005.06.018. [PMID: 16183420] - Bradley A Warady, R Howard Zobrist, Jingyang Wu, Eileen Finan. Sodium ferric gluconate complex therapy in anemic children on hemodialysis.
Pediatric nephrology (Berlin, Germany).
2005 Sep; 20(9):1320-7. doi:
10.1007/s00467-005-1904-y. [PMID: 15971073] - Beckie Michael. The safety of sodium ferric gluconate complex in haemodialysis patients has been extensively evaluated.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2005 Aug; 20(8):1770. doi:
10.1093/ndt/gfh936. [PMID: 15956060] - Christopher J Earley, Debbie Heckler, Richard P Allen. Repeated IV doses of iron provides effective supplemental treatment of restless legs syndrome.
Sleep medicine.
2005 Jul; 6(4):301-5. doi:
10.1016/j.sleep.2005.01.008. [PMID: 15978514] - George R Bailie, John A Clark, Christi E Lane, Peter L Lane. Hypersensitivity reactions and deaths associated with intravenous iron preparations.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2005 Jul; 20(7):1443-9. doi:
10.1093/ndt/gfh820. [PMID: 15855210] - Dipankarc Bhowmik, Suresh C Tiwari. Do we need to change our administration practice with regard to sodium ferric gluconate complex in glucose?.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2005 Jun; 20(6):1279. doi:
10.1093/ndt/gfh552. [PMID: 15797892] - Antonion Giordano, Girolamo Arrigo, Fausto Lavarda, Giuliano Colasanti, Concetta Petrini. Comparison of two iron gluconate treatment modalities in chronic hemodialysis patients: results of a randomized trial.
Journal of nephrology.
2005 Mar; 18(2):181-7. doi:
NULL. [PMID: 15931646] - Peter Yorgin. Intravenous iron therapy in pediatric transplant recipients: what do we really know?.
Pediatric transplantation.
2005 Feb; 9(1):1-3. doi:
10.1111/j.1399-3046.2005.00269.x. [PMID: 15667602] - Robert S Gillespie, Jordan M Symons. Sodium ferric gluconate for post-transplant anemia in pediatric and young adult renal transplant recipients.
Pediatric transplantation.
2005 Feb; 9(1):43-6. doi:
10.1111/j.1399-3046.2005.00258.x. [PMID: 15667610] - Jasmina Mimić-Oka, A Savić-Radojević, M Pljesa-Ercegovac, M Opacić, T Simić, N Dimković, D V Simić. Evaluation of oxidative stress after repeated intravenous iron supplementation.
Renal failure.
2005; 27(3):345-51. doi:
10.1081/jdi-56599. [PMID: 15957553] - David J Leehey, David J Palubiak, Srivasa Chebrolu, Rajiv Agarwal. Sodium ferric gluconate causes oxidative stress but not acute renal injury in patients with chronic kidney disease: a pilot study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2005 Jan; 20(1):135-40. doi:
10.1093/ndt/gfh565. [PMID: 15522899] - Magdalena Hodkova, Sylvie Dusilova-Sulkova, Anna Skalicka, Marta Kalousova, Tomas Zima, Jirina Bartunkova. Influence of parenteral iron therapy and oral vitamin E supplementation on neutrophil respiratory burst in chronic hemodialysis patients.
Renal failure.
2005; 27(2):135-41. doi:
NULL. [PMID: 15807176] - C Nailescu, M Castaneda, M Del Rio, J T Flynn. Iron supplementation in adolescent hemodialysis patients.
Clinical nephrology.
2004 Dec; 62(6):449-54. doi:
10.5414/cnp62449. [PMID: 15630904] - M K Riedel, T Morgenstern. [Iron replacement in hemodialysis patients with a normal serum ferritin level].
Deutsche medizinische Wochenschrift (1946).
2004 Sep; 129(36):1849-53. doi:
10.1055/s-2004-831347. [PMID: 15368155] - Rajiv Agarwal. Transferrin saturation with intravenous irons: an in vitro study.
Kidney international.
2004 Sep; 66(3):1139-44. doi:
10.1111/j.1523-1755.2004.00864.x. [PMID: 15327409] - Richard A Zager, Ali C M Johnson, Sherry Y Hanson. Parenteral iron nephrotoxicity: potential mechanisms and consequences.
Kidney international.
2004 Jul; 66(1):144-56. doi:
10.1111/j.1523-1755.2004.00716.x. [PMID: 15200421] - Caterina Canavese, Daniela Bergamo, Giovannino Ciccone, Manuel Burdese, Emanuela Maddalena, Sara Barbieri, Alessandra Thea, Fabrizio Fop. Low-dose continuous iron therapy leads to a positive iron balance and decreased serum transferrin levels in chronic haemodialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2004 Jun; 19(6):1564-70. doi:
10.1093/ndt/gfh136. [PMID: 15004263] - Glenn M Chertow, Phillip D Mason, Odd Vaage-Nilsen, Jarl Ahlmén. On the relative safety of parenteral iron formulations.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2004 Jun; 19(6):1571-5. doi:
10.1093/ndt/gfh185. [PMID: 15150356] - Paul A Seligman, Naomi V Dahl, Jur Strobos, Hui C Kimko, Rhoda B Schleicher, Michael Jones, Murray P Ducharme. Single-dose pharmacokinetics of sodium ferric gluconate complex in iron-deficient subjects.
Pharmacotherapy.
2004 May; 24(5):574-83. doi:
10.1592/phco.24.6.574.34750. [PMID: 15162891] - David Van Wyck, Jaime Anderson, Kevin Johnson. Labile iron in parenteral iron formulations: a quantitative and comparative study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2004 Mar; 19(3):561-5. doi:
10.1093/ndt/gfg579. [PMID: 14767009] - Ratna S Danda, Linda J Kirk, Pablo E Pergola. High-dose iron gluconate in chronic kidney disease patients.
Nephrology (Carlton, Vic.).
2004 Feb; 9(1):47-8. doi:
10.1111/j.1440-1797.2003.00220.x. [PMID: 14996310] - Michael E Ullian, Crystal A Gadegbeku. Effects of intravenously administered iron on systemic blood pressure in hemodialysis patients.
Nephron. Clinical practice.
2004; 98(3):c83-6. doi:
10.1159/000080678. [PMID: 15528942] - Peter Geisser. Reactivity of iron compounds.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2003 Nov; 42(5):1103-4. doi:
10.1016/j.ajkd.2003.08.008. [PMID: 14582056] - Kamyar Kalantar-Zadeh, Charles J McAllister, Robert S Lehn, Grace H Lee, Allen R Nissenson, Joel D Kopple. Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2003 Oct; 42(4):761-73. doi:
10.1016/s0272-6386(03)00915-6. [PMID: 14520627] - Vaughn W Folkert. Intravenous iron therapy in chronic kidney disease and peritoneal dialysis patients.
Nephrology nursing journal : journal of the American Nephrology Nurses' Association.
2003 Oct; 30(5):571-6, 584. doi:
NULL. [PMID: 14621635] - Javier Deira, Julia Diego, Rosa Martínez, Amaya Oyarbide, Anunciación González, Hugo Díaz, Jesús Grande. Comparative study of intravenous ascorbic acid versus low-dose desferroxamine in patients on hemodialysis with hyperferritinemia.
Journal of nephrology.
2003 Sep; 16(5):703-9. doi:
NULL. [PMID: 14733417] - Markus Kosch, Roland M Schaefer. [Indications and practical management of parenteral iron therapy].
Wiener klinische Wochenschrift.
2003 Jun; 115(11):380-4. doi:
10.1007/bf03040356. [PMID: 12879735] - Regina Michelis, Rafi Gery, Shifra Sela, Revital Shurtz-Swirski, Natalie Grinberg, Tamara Snitkovski, Shaul M Shasha, Batya Kristal. Carbonyl stress induced by intravenous iron during haemodialysis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2003 May; 18(5):924-30. doi:
10.1093/ndt/gfg031. [PMID: 12686666] - Vaughn W Folkert, Beckie Michael, Rajiv Agarwal, Daniel W Coyne, Naomi Dahl, Pamela Myirski, David G Warnock. Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose (> or =250 mg) administration.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2003 Mar; 41(3):651-7. doi:
10.1053/ajkd.2003.50141. [PMID: 12612989] - Bahar Bastani, Anil Jain, Gopal Pandurangan. Incidence of side-effects associated with high-dose ferric gluconate in patients with severe chronic renal failure.
Nephrology (Carlton, Vic.).
2003 Feb; 8(1):8-10. doi:
10.1046/j.1440-1797.2003.00118.x. [PMID: 15012743] - Daniel W Coyne, N Franklin Adkinson, Allen R Nissenson, Steven Fishbane, Rajiv Agarwal, Joseph W Eschbach, Beckie Michael, Vaughn Folkert, Daniel Batlle, J Richard Trout, Naomi Dahl, Pamela Myirski, Jur Strobos, David G Warnock. Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients.
Kidney international.
2003 Jan; 63(1):217-24. doi:
10.1046/j.1523-1755.2003.00703.x. [PMID: 12472786] - J R Rodríguez Palomares, B Fanlo, C Albarracín, E Junquera. [Changes in iron metabolism and erythropoietin requirements after the switch from ferric gluconate to iron saccharose. Is it worth the increased expense?].
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.
2003; 23(2):181-2. doi:
NULL. [PMID: 12778887] - Atinder Panesar, Rajiv Agarwal. Safety and efficacy of sodium ferric gluconate complex in patients with chronic kidney disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2002 Nov; 40(5):924-31. doi:
10.1053/ajkd.2002.36322. [PMID: 12407636] - Anil K Jain, Bahar Bastani. Safety profile of a high dose ferric gluconate in patients with severe chronic renal insufficiency.
Journal of nephrology.
2002 Nov; 15(6):681-3. doi:
NULL. [PMID: 12495284] - Richard A Zager, Ali C M Johnson, Sherry Y Hanson, Haimanot Wasse. Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2002 Jul; 40(1):90-103. doi:
10.1053/ajkd.2002.33917. [PMID: 12087566]